Savio L. C. Woo
University of Pittsburgh
785 Papers
16.4K Citations
Savio L. C. Woo is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Anterior cruciate ligament & Phenylalanine hydroxylase. The author has an hindex of 135, co-authored 785 publications. Previous affiliations of Savio L. C. Woo include University of California, San Diego & Texas Medical Center.
Chat about Author
Papers
Improvement of accuracy in a high-capacity, six degree-of-freedom load cell : Application to robotic testing of musculoskeletal joints
Lars G. Gilbertson,Todd C. Doehring,Glen A. Livesay,Theodore W. Rudy,James D. Kang,Savio L. C. Woo +5 more
TL;DR: Implementation of the calibration protocol reduced the error caused by changes in universal force-moment sensor (UFS) orientation within a gravitational field by approximately 75% and should improve both the measurement and control of specimen kinetics by robotic/UFS and other biomechanical testing systems.
31
Sequence comparison of rat liver phenylalanine hydroxylase and its cDNA clones.
TL;DR: A perfect match of 17 amino acid residues was found between the two sequences following a unique methionine codon present in the nucleotide sequence, thereby providing unambiguous evidence for the identity of the rat liver phenylalanine hydroxylase cDNA clones.
31
•Journal Article
Adenovirus-mediated thymidine kinase gene transduction in human epithelial ovarian cancer cell lines followed by exposure to ganciclovir
TL;DR: Cell killing efficacy and toxicity of adenovirus-mediated transfer of the HSV-TK gene followed by administration of ganciclovir were studied in two human epithelial ovarian cancer cell lines and ADV/RSV- TK mediated gene therapy may be a promising approach in ovarian cancer.
31
Treatment of multi-focal colorectal carcinoma metastatic to the liver of immune-competent and syngeneic rats by hepatic artery infusion of oncolytic vesicular stomatitis virus
TL;DR: It is demonstrated that hepatic arterial administration of oncolytic VSV is both effective and safe in an immune‐competent and syngeneic rat model of multi‐focal CRC liver metastasis, suggesting that it can be developed into an effective therapeutic modality in patients in the future.
30